Myocardial scintigraphy with 99mTc-pyrophosphate in the diagnosis of cardiac amyloidosis: place in the diagnostic algorithm, features of the implementation and interpretation of the study
- Authors: Ansheles A.A.1, Nasonova S.N.1, Zhirov I.V.1, Saidova M.A.1, Stukalova O.V.1, Tereshchenko S.N.1, Sergienko V.B.1
-
Affiliations:
- Chazov National Medical Research Center of Cardiology
- Issue: Vol 94, No 4 (2022)
- Pages: 530-537
- Section: Original articles
- URL: https://journals.rcsi.science/0040-3660/article/view/108235
- DOI: https://doi.org/10.26442/00403660.2022.04.201461
- ID: 108235
Cite item
Full Text
Abstract
The article summarizes the current experience of the nuclear medicine department of the Chazov National Medical Research Center of Cardiology in the implementation of myocardium scintigraphy with 99mTc-pyrophosphate with the differential diagnosis of the types of cardiac amyloidosis. Causes of false-positive, equivocal and non-diagnostic results, are analyzed. Possible ways to eliminate mistakes, including by modifying protocols of planar and tomographic research and optimizing the whole diagnostic algorithm for amyloidosis of the heart, are discussed.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Alexey A. Ansheles
Chazov National Medical Research Center of Cardiology
Author for correspondence.
Email: a.ansheles@gmail.com
ORCID iD: 0000-0002-2675-3276
д-р мед. наук, ст. науч. сотр. отд. радионуклидной диагностики и позитронно-эмиссионной томографии
Russian Federation, MoscowSvetlana N. Nasonova
Chazov National Medical Research Center of Cardiology
Email: a.ansheles@gmail.com
ORCID iD: 0000-0002-0920-7417
канд. мед. наук, ст. науч. сотр. отд. заболеваний миокарда и сердечной недостаточности
Russian Federation, MoscowIgor V. Zhirov
Chazov National Medical Research Center of Cardiology
Email: a.ansheles@gmail.com
ORCID iD: 0000-0002-4066-2661
д-р мед. наук, вед. науч. сотр. отд. заболеваний миокарда и сердечной недостаточности
Russian Federation, MoscowMarina A. Saidova
Chazov National Medical Research Center of Cardiology
Email: a.ansheles@gmail.com
ORCID iD: 0000-0002-3233-1862
д-р мед. наук, проф., рук. отд. ультразвуковых методов исследования
Russian Federation, MoscowOlga V. Stukalova
Chazov National Medical Research Center of Cardiology
Email: a.ansheles@gmail.com
ORCID iD: 0000-0001-8377-2388
канд. мед. наук, ст. науч. сотр. отд. томографии
Russian Federation, MoscowSergey N. Tereshchenko
Chazov National Medical Research Center of Cardiology
Email: a.ansheles@gmail.com
ORCID iD: 0000-0001-9234-6129
д-р мед. наук, проф., рук. отд. заболеваний миокарда и сердечной недостаточности
Russian Federation, MoscowVladimir B. Sergienko
Chazov National Medical Research Center of Cardiology
Email: a.ansheles@gmail.com
ORCID iD: 0000-0002-0487-6902
д-р мед. наук, проф., рук. отд. радионуклидной диагностики и позитронно-эмиссионной томографии
Russian Federation, MoscowReferences
- Siddiqi OK, Ruberg FL. Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment. Trends Cardiovasc Med. 2018;28(1):10-21. doi: 10.1016/j.tcm.2017.07.004
- Donnelly JP, Hanna M. Cardiac amyloidosis: An update on diagnosis and treatment. Cleve Clin J Med. 2017;84(12 Suppl. 3):12-26. doi: 10.3949/ccjm.84.s3.02
- Dubrey SW, Hawkins PN, Falk RH. Amyloid diseases of the heart: assessment, diagnosis, and referral. Heart. 2011;97(1):75-84. doi: 10.1136/hrt.2009.190405
- Shah KB, Inoue Y, Mehra MR. Amyloidosis and the heart: a comprehensive review. Arch Intern Med. 2006;166(17):1805-13. doi: 10.1001/archinte.166.17.1805
- Phelan D, Collier P, Thavendiranathan P, et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart. 2012;98(19):1442-8. doi: 10.1136/heartjnl-2012-302353
- Fontana M, Pica S, Reant P, et al. Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis. Circulation. 2015;132(16):1570-9. doi: 10.1161/CIRCULATIONAHA.115.016567
- Rapezzi C, Merlini G, Quarta CC, et al. Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation. 2009;120(13):1203-12. doi: 10.1161/CIRCULATIONAHA.108.843334
- Dorbala S, Ando Y, Bokhari S, et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. J Nucl Cardiol. 2019;26(6):2065-123. doi: 10.1007/s12350-019-01760-6
- Gillmore JD, Maurer MS, Falk RH, et al. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. Circulation. 2016;133(24):2404-12. doi: 10.1161/CIRCULATIONAHA.116.021612
- Perugini E, Guidalotti PL, Salvi F, et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol. 2005;46(6):1076-84. doi: 10.1016/j.jacc.2005.05.073
- Сергиенко В.Б., Терещенко С.Н., Аншелес А.А., и др. Радионуклидные методы в диагностике амилоидоза сердца. Рациональная фармакотерапия в кардиологии. 2018;14(1):94-100 [Sergienko VB, Tereshchenko SN, Ansheles AA, et al. Nuclear imaging in the diagnosis of cardiac amyloidosis. Rational Pharmacotherapy in Cardiology. 2018;14(1):94-100 (in Russian)]. doi: 10.20996/1819-6446-2018-14-1-94-100
- Rapezzi C, Quarta CC, Guidalotti PL, et al. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. JACC Cardiovasc Imaging. 2011;4(6):659-70. doi: 10.1016/j.jcmg.2011.03.016
- Bokhari S, Castano A, Pozniakoff T, et al. 99mTc-Pyrophosphate Scintigraphy for Differentiating Light-Chain Cardiac Amyloidosis From the Transthyretin-Related Familial and Senile Cardiac Amyloidoses. Circ Cardiovasc Imaging. 2013;6(2):195-201. doi: 10.1161/circimaging.112.000132
- Аншелес А.А., Сергиенко В.Б. Вопросы стандартизации метода нейротропной сцинтиграфии и однофотонной эмиссионной томографии миокарда с 123I-метайодбензилгуанидином. Вестник рентгенологии и радиологии. 2016;97(3):173-80 [Ansheles AA, Sergienko VB. Standardization of 123I-metaiodobenzylguanidine cardiac neurotropic scintigraphy and single-photon emission tomography. Vestnik Rentgenologii i Radiologii (Russian Journal of Radiology). 2016;97(3):173-80 (in Russian)]. doi: 10.20862/0042-4676-2016-97-3-173-180
- Dorbala S, Ando Y, Bokhari S, et al. Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. J Nucl Cardiol. 2021;28(4):1769-74. doi: 10.1007/s12350-020-02455-z